_id
691856103c536f8df231797f
Ticker
0HI3.LSE
Name
Arrowhead Pharmaceuticals Corp.
Exchange
LSE
Address
177 East Colorado Boulevard, Pasadena, CA, United States, 91105
Country
UK
Sector
Industry
Currency
USD
Website
https://arrowheadpharma.com
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
Last Close
66.15
Volume
100
Current Price
66.15
Change
1.7
Last Updated
2026-01-08T13:52:38.340Z
Image
https://logo.clearbit.com/arrowheadpharma.com
Ipo Date
-
Market Cap
634288128000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
27767000
Cost Of Revenue
6223000
Gross Profit
21544000
Operating Expenses
187094000
Operating Income
-165550000
Interest Expense
24382000
Pretax Income
-175678000
Net Income
-175241000
Eps
-1.2603729888736255
Dividends Per Share
-
Shares Outstanding
88023104
Income Tax Expense
2974000
EBITDA
-148484000
Operating Margin
-596.2113299960384
Total Other Income Expense Net
-10128000
Cash
129793000
Short Term Investments
770579000
Receivables
9699000
Inventories
-
Total Current Assets
946923000
Property Plant Equipment
425050000
Total Assets
1380612000
Payables
33050000
Short Term Debt
47010000
Long Term Debt
-
Total Liabilities
860806000
Equity
522313000
Bs_currency_symbol
-
Depreciation
1678000
Change In Working Capital
-17960000
Cash From Operations
-154720000
Capital Expenditures
2364000
Cash From Investing
141390000
Cash From Financing
-42679000
Net Change In Cash
-55916000
Cf_currency_symbol
USD
PE
-
PB
17.609038737308857
ROE
-33.55095507865973
ROA
-12.69299412144759
FCF
-157084000
Fcf Percent
-5.657219000972377
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
1.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
1.5
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
27767000
Quarters > 0 > income Statement > cost Of Revenue
6223000
Quarters > 0 > income Statement > gross Profit
21544000
Quarters > 0 > income Statement > operating Expenses
187094000
Quarters > 0 > income Statement > operating Income
-165550000
Quarters > 0 > income Statement > interest Expense
24382000
Quarters > 0 > income Statement > pretax Income
-175678000
Quarters > 0 > income Statement > net Income
-175241000
Quarters > 0 > income Statement > eps
-1.2603729888736255
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
139039000
Quarters > 0 > income Statement > income Tax Expense
2974000
Quarters > 0 > income Statement > EBITDA
-148484000
Quarters > 0 > income Statement > operating Margin
-596.2113299960384
Quarters > 0 > income Statement > total Other Income Expense Net
-10128000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
129793000
Quarters > 0 > balance Sheet > short Term Investments
770579000
Quarters > 0 > balance Sheet > receivables
9699000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
946923000
Quarters > 0 > balance Sheet > property Plant Equipment
425050000
Quarters > 0 > balance Sheet > total Assets
1380612000
Quarters > 0 > balance Sheet > payables
33050000
Quarters > 0 > balance Sheet > short Term Debt
47010000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
860806000
Quarters > 0 > balance Sheet > equity
522313000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-178652000
Quarters > 0 > cash Flow > depreciation
1678000
Quarters > 0 > cash Flow > change In Working Capital
-17960000
Quarters > 0 > cash Flow > cash From Operations
-154720000
Quarters > 0 > cash Flow > capital Expenditures
2364000
Quarters > 0 > cash Flow > cash From Investing
141390000
Quarters > 0 > cash Flow > cash From Financing
-42679000
Quarters > 0 > cash Flow > net Change In Cash
-55916000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.2603729888736255
Quarters > 0 > ratios > PB
17.609038737308857
Quarters > 0 > ratios > ROE
-33.55095507865973
Quarters > 0 > ratios > ROA
-12.69299412144759
Quarters > 0 > ratios > FCF
-157084000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-5.657219000972377
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
542709000
Quarters > 1 > income Statement > cost Of Revenue
6084000
Quarters > 1 > income Statement > gross Profit
542709000
Quarters > 1 > income Statement > operating Expenses
161507000
Quarters > 1 > income Statement > operating Income
381202000
Quarters > 1 > income Statement > interest Expense
21639000
Quarters > 1 > income Statement > pretax Income
369616000
Quarters > 1 > income Statement > net Income
370445000
Quarters > 1 > income Statement > eps
2.7545655988816513
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
134484000
Quarters > 1 > income Statement > income Tax Expense
1753000
Quarters > 1 > income Statement > EBITDA
397339000
Quarters > 1 > income Statement > operating Margin
70.2405893397751
Quarters > 1 > income Statement > total Other Income Expense Net
-11586000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
185709000
Quarters > 1 > balance Sheet > short Term Investments
911700000
Quarters > 1 > balance Sheet > receivables
2365000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1135220000
Quarters > 1 > balance Sheet > property Plant Equipment
429255000
Quarters > 1 > balance Sheet > total Assets
1573498000
Quarters > 1 > balance Sheet > payables
9980000
Quarters > 1 > balance Sheet > short Term Debt
71782000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
889273000
Quarters > 1 > balance Sheet > equity
683321000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
367863000
Quarters > 1 > cash Flow > depreciation
6084000
Quarters > 1 > cash Flow > change In Working Capital
45525000
Quarters > 1 > cash Flow > cash From Operations
460053000
Quarters > 1 > cash Flow > capital Expenditures
5297000
Quarters > 1 > cash Flow > cash From Investing
-420213000
Quarters > 1 > cash Flow > cash From Financing
92382000
Quarters > 1 > cash Flow > net Change In Cash
131820000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
2.7545655988816513
Quarters > 1 > ratios > PB
13.018942195542067
Quarters > 1 > ratios > ROE
54.212441883097405
Quarters > 1 > ratios > ROA
23.54276904069786
Quarters > 1 > ratios > FCF
454756000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.8379370896742084
Quarters > 1 > health Score
76
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
2500000
Quarters > 2 > income Statement > cost Of Revenue
5235000
Quarters > 2 > income Statement > gross Profit
2500000
Quarters > 2 > income Statement > operating Expenses
163912000
Quarters > 2 > income Statement > operating Income
-161412000
Quarters > 2 > income Statement > interest Expense
21646000
Quarters > 2 > income Statement > pretax Income
-175115000
Quarters > 2 > income Statement > net Income
-173085000
Quarters > 2 > income Statement > eps
-1.386365820838139
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
124848000
Quarters > 2 > income Statement > income Tax Expense
103000
Quarters > 2 > income Statement > EBITDA
-148234000
Quarters > 2 > income Statement > operating Margin
-6456.4800000000005
Quarters > 2 > income Statement > total Other Income Expense Net
-13703000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
53889000
Quarters > 2 > balance Sheet > short Term Investments
499046000
Quarters > 2 > balance Sheet > receivables
2500000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
570536000
Quarters > 2 > balance Sheet > property Plant Equipment
431938000
Quarters > 2 > balance Sheet > total Assets
1013694000
Quarters > 2 > balance Sheet > payables
14457000
Quarters > 2 > balance Sheet > short Term Debt
8185000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
957619000
Quarters > 2 > balance Sheet > equity
52589000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-175218000
Quarters > 2 > cash Flow > depreciation
5235000
Quarters > 2 > cash Flow > change In Working Capital
-7440000
Quarters > 2 > cash Flow > cash From Operations
-146272000
Quarters > 2 > cash Flow > capital Expenditures
7516000
Quarters > 2 > cash Flow > cash From Investing
76910000
Quarters > 2 > cash Flow > cash From Financing
20634000
Quarters > 2 > cash Flow > net Change In Cash
-48796000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.386365820838139
Quarters > 2 > ratios > PB
157.04225598509197
Quarters > 2 > ratios > ROE
-329.12776436136835
Quarters > 2 > ratios > ROA
-17.074679341102936
Quarters > 2 > ratios > FCF
-153788000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-61.5152
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
23589000
Quarters > 3 > income Statement > cost Of Revenue
13570000
Quarters > 3 > income Statement > gross Profit
10019000
Quarters > 3 > income Statement > operating Expenses
162203000
Quarters > 3 > income Statement > operating Income
-162203000
Quarters > 3 > income Statement > interest Expense
14647000
Quarters > 3 > income Statement > pretax Income
-172798000
Quarters > 3 > income Statement > net Income
-170536000
Quarters > 3 > income Statement > eps
-1.3979334625773108
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
121991500
Quarters > 3 > income Statement > income Tax Expense
546000
Quarters > 3 > income Statement > EBITDA
-153126000
Quarters > 3 > income Statement > operating Margin
-687.6213489338251
Quarters > 3 > income Statement > total Other Income Expense Net
-10595000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
102685000
Quarters > 3 > balance Sheet > short Term Investments
578276000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
695471000
Quarters > 3 > balance Sheet > property Plant Equipment
431287000
Quarters > 3 > balance Sheet > total Assets
1139802000
Quarters > 3 > balance Sheet > payables
11388000
Quarters > 3 > balance Sheet > short Term Debt
6342000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
948739000
Quarters > 3 > balance Sheet > equity
185444000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-173344000
Quarters > 3 > cash Flow > depreciation
5025000
Quarters > 3 > cash Flow > change In Working Capital
7952000
Quarters > 3 > cash Flow > cash From Operations
-137216000
Quarters > 3 > cash Flow > capital Expenditures
24289000
Quarters > 3 > cash Flow > cash From Investing
-222923000
Quarters > 3 > cash Flow > cash From Financing
389089000
Quarters > 3 > cash Flow > net Change In Cash
33286000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.3979334625773108
Quarters > 3 > ratios > PB
43.51576608032614
Quarters > 3 > ratios > ROE
-91.96091542460258
Quarters > 3 > ratios > ROA
-14.961896890863501
Quarters > 3 > ratios > FCF
-161505000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-6.846623426173216
Quarters > 3 > health Score
9
Annuals > 0 > quarter
2025-09-30
Annuals > 0 > income Statement > revenue
829448000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
731102000
Annuals > 0 > income Statement > operating Income
98346000
Annuals > 0 > income Statement > interest Expense
89361000
Annuals > 0 > income Statement > pretax Income
19788000
Annuals > 0 > income Statement > net Income
-1631000
Annuals > 0 > income Statement > eps
-0.0121936631827629
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
133758000
Annuals > 0 > income Statement > income Tax Expense
21419000
Annuals > 0 > income Statement > EBITDA
98346000
Annuals > 0 > income Statement > operating Margin
11.856801149680269
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
226548000
Annuals > 0 > balance Sheet > short Term Investments
692818000
Annuals > 0 > balance Sheet > receivables
6824000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
950639000
Annuals > 0 > balance Sheet > property Plant Equipment
426406000
Annuals > 0 > balance Sheet > total Assets
1450438000
Annuals > 0 > balance Sheet > payables
17674000
Annuals > 0 > balance Sheet > short Term Debt
47289000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
947022000
Annuals > 0 > balance Sheet > equity
466052000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
30114000
Annuals > 0 > cash Flow > depreciation
23928000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
179552000
Annuals > 0 > cash Flow > capital Expenditures
22666000
Annuals > 0 > cash Flow > cash From Investing
-129294000
Annuals > 0 > cash Flow > cash From Financing
74006000
Annuals > 0 > cash Flow > net Change In Cash
124264000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.0121936631827629
Annuals > 0 > ratios > PB
18.98520272415954
Annuals > 0 > ratios > ROE
-0.3499609485636796
Annuals > 0 > ratios > ROA
-0.11244879133061876
Annuals > 0 > ratios > FCF
156886000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.18914506997424793
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2024-09-30
Annuals > 1 > income Statement > revenue
3551000
Annuals > 1 > income Statement > cost Of Revenue
18595000
Annuals > 1 > income Statement > gross Profit
3551000
Annuals > 1 > income Statement > operating Expenses
604631000
Annuals > 1 > income Statement > operating Income
-601080000
Annuals > 1 > income Statement > interest Expense
32352000
Annuals > 1 > income Statement > pretax Income
-612460000
Annuals > 1 > income Statement > net Income
-599493000
Annuals > 1 > income Statement > eps
-5.004783610498898
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
119784000
Annuals > 1 > income Statement > income Tax Expense
-2767000
Annuals > 1 > income Statement > EBITDA
-561513000
Annuals > 1 > income Statement > operating Margin
-16927.06279921149
Annuals > 1 > income Statement > total Other Income Expense Net
-11380000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
102685000
Annuals > 1 > balance Sheet > short Term Investments
578276000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
695471000
Annuals > 1 > balance Sheet > property Plant Equipment
431287000
Annuals > 1 > balance Sheet > total Assets
1139802000
Annuals > 1 > balance Sheet > payables
11388000
Annuals > 1 > balance Sheet > short Term Debt
6342000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
948739000
Annuals > 1 > balance Sheet > equity
185444000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-609693000
Annuals > 1 > cash Flow > depreciation
18595000
Annuals > 1 > cash Flow > change In Working Capital
25091000
Annuals > 1 > cash Flow > cash From Operations
-462851000
Annuals > 1 > cash Flow > capital Expenditures
141469000
Annuals > 1 > cash Flow > cash From Investing
-420072000
Annuals > 1 > cash Flow > cash From Financing
870520000
Annuals > 1 > cash Flow > net Change In Cash
-8206000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-5.004783610498898
Annuals > 1 > ratios > PB
42.72832553223615
Annuals > 1 > ratios > ROE
-323.2744116822329
Annuals > 1 > ratios > ROA
-52.596240399648366
Annuals > 1 > ratios > FCF
-604320000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-170.1830470290059
Annuals > 1 > health Score
8
Annuals > 2 > quarter
2023-09-30
Annuals > 2 > income Statement > revenue
240735000
Annuals > 2 > income Statement > cost Of Revenue
12493000
Annuals > 2 > income Statement > gross Profit
240735000
Annuals > 2 > income Statement > operating Expenses
445737000
Annuals > 2 > income Statement > operating Income
-205002000
Annuals > 2 > income Statement > interest Expense
18326000
Annuals > 2 > income Statement > pretax Income
-206491000
Annuals > 2 > income Statement > net Income
-205275000
Annuals > 2 > income Statement > eps
-1.9229508196721312
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
106750000
Annuals > 2 > income Statement > income Tax Expense
2784000
Annuals > 2 > income Statement > EBITDA
-175672000
Annuals > 2 > income Statement > operating Margin
-85.15670758302699
Annuals > 2 > income Statement > total Other Income Expense Net
-1489000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
110891000
Annuals > 2 > balance Sheet > short Term Investments
292735000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
419521000
Annuals > 2 > balance Sheet > property Plant Equipment
335559000
Annuals > 2 > balance Sheet > total Assets
765552000
Annuals > 2 > balance Sheet > payables
35866000
Annuals > 2 > balance Sheet > short Term Debt
10563000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
478390000
Annuals > 2 > balance Sheet > equity
271343000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-209275000
Annuals > 2 > cash Flow > depreciation
12493000
Annuals > 2 > cash Flow > change In Working Capital
-51547000
Annuals > 2 > cash Flow > cash From Operations
-153890000
Annuals > 2 > cash Flow > capital Expenditures
176737000
Annuals > 2 > cash Flow > cash From Investing
-96155000
Annuals > 2 > cash Flow > cash From Financing
253053000
Annuals > 2 > cash Flow > net Change In Cash
2886000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.9229508196721312
Annuals > 2 > ratios > PB
26.024303188215654
Annuals > 2 > ratios > ROE
-75.65148170396878
Annuals > 2 > ratios > ROA
-26.813985202834033
Annuals > 2 > ratios > FCF
-330627000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.3734064427690198
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2022-09-30
Annuals > 3 > income Statement > revenue
243231000
Annuals > 3 > income Statement > cost Of Revenue
10421000
Annuals > 3 > income Statement > gross Profit
243231000
Annuals > 3 > income Statement > operating Expenses
421738000
Annuals > 3 > income Statement > operating Income
-178507000
Annuals > 3 > income Statement > interest Expense
5033000
Annuals > 3 > income Statement > pretax Income
-172709000
Annuals > 3 > income Statement > net Income
-176063000
Annuals > 3 > income Statement > eps
-1.6700149868153966
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
105426000
Annuals > 3 > income Statement > income Tax Expense
3785000
Annuals > 3 > income Statement > EBITDA
-162288000
Annuals > 3 > income Statement > operating Margin
-73.38990506966628
Annuals > 3 > income Statement > total Other Income Expense Net
5798000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
108005000
Annuals > 3 > balance Sheet > short Term Investments
268391000
Annuals > 3 > balance Sheet > receivables
1410000
Annuals > 3 > balance Sheet > inventories
-21614000
Annuals > 3 > balance Sheet > total Current Assets
405299000
Annuals > 3 > balance Sheet > property Plant Equipment
168588000
Annuals > 3 > balance Sheet > total Assets
691939000
Annuals > 3 > balance Sheet > payables
2868000
Annuals > 3 > balance Sheet > short Term Debt
2776000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
273600000
Annuals > 3 > balance Sheet > equity
398520000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-176494000
Annuals > 3 > cash Flow > depreciation
10421000
Annuals > 3 > cash Flow > change In Working Capital
-98293000
Annuals > 3 > cash Flow > cash From Operations
-136131000
Annuals > 3 > cash Flow > capital Expenditures
52777000
Annuals > 3 > cash Flow > cash From Investing
-5417000
Annuals > 3 > cash Flow > cash From Financing
65186000
Annuals > 3 > cash Flow > net Change In Cash
-76429000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.6700149868153966
Annuals > 3 > ratios > PB
17.499573170731708
Annuals > 3 > ratios > ROE
-44.17921308842718
Annuals > 3 > ratios > ROA
-25.444873030715137
Annuals > 3 > ratios > FCF
-188908000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.7766608697082198
Annuals > 3 > health Score
22
Valuation > metrics > PE
-1.2603729888736255
Valuation > metrics > PB
17.609038737308857
Valuation > final Score
20
Valuation > verdict
487.0% Overvalued
Profitability > metrics > ROE
-33.55095507865973
Profitability > metrics > ROA
-18.506362185732105
Profitability > metrics > Net Margin
-6.311124716389959
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.6480654320302195
Risk > metrics > Interest Coverage
-6.789844967599048
Risk > final Score
3
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.827666749937547
Liquidity > metrics > Quick Ratio
11.827666749937547
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
100
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
70
Prev Risks > 1
-24
Prev Risks > 2
-38
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:53:29.848Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-11
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-09
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-0.07
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.2604
Earnings History > 2 > eps Estimate
-1.1
Earnings History > 2 > eps Difference
-0.1604
Earnings History > 2 > surprise Percent
-14.5818
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-12
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
2.7546
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-10
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.3864
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-27
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.3711
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.3752
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.0163
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-14
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.2369
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-29
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.0221
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-07
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.9621
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-02
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.4501
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-06
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.3897
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-28
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.807
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-04
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.6813
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-10
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.4111
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-02
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.6015
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-22
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.6075
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-05
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.2875
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-04
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.2582
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.2018
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.4731
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.1336
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.1951
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.0275
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
0.12
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-06-30
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
0.2057
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
0.2436
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2018-12-31
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
0.1259
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-09-30
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.1216
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.1781
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-03-31
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.177
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Arrowhead Pharmaceuticals Corp.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.07
Date
2025-06-30
EPS Actual
-1.2604
EPS Estimate
-1.1
EPS Difference
-0.1604
Surprise Percent
-14.5818%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.